ReproCELL Incorporated

4978

TSE PrimeChemicals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2027 Q1

Revenue

23100M JPY

YoY -18.7%

Operating Income

-3.1100M JPY

YoY -6.8%

Net Income

-4.4100M JPY

YoY -247.2%

EPS

-1.6JPY

YoY +51.4%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

29.8億円

20.2億円

10.6億円

99.6百万円

-8.6億円

Rev: 22.3億円Op: -6.5億円NI: -5.8億円

Rev: 29.5億円Op: -3.6億円NI: -3.1億円

Rev: 24.3億円Op: -4.1億円NI: -31.4百万円

Rev: 29.8億円Op: -1.3億円NI: 1億円

Rev: 22.3億円Op: -8.6億円NI: -5.9億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income32.5%

Revenue Progress5.500M

Revenue Forecast26.300M

Net Income Progress-1.500M

Net Income Forecast-4.600M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan